Tricida Inc. (TCDA) is a Biotechnology: Pharmaceutical Preparations company listed on NASDAQ. There were no new wire items for TCDA in the last 30 days. The most recent was published Jun 20, 2023.
Latest news
25 items- SECSEC Form EFFECT filed by Tricida Inc.EFFECT - Tricida, Inc. (0001595585) (Filer)
- SECSEC Form 15-12G filed by Tricida Inc.15-12G - Tricida, Inc. (0001595585) (Filer)
- SECSEC Form S-8 POS filed by Tricida Inc.S-8 POS - Tricida, Inc. (0001595585) (Filer)
- SECSEC Form POSASR filed by Tricida Inc.POSASR - Tricida, Inc. (0001595585) (Filer)
- SECSEC Form POS AM filed by Tricida Inc.POS AM - Tricida, Inc. (0001595585) (Filer)
- SECTricida Inc. filed SEC Form 8-K: Bankruptcy or Receivership, Material Modification to Rights of Security Holders, Other Events, Financial Statements and Exhibits8-K - Tricida, Inc. (0001595585) (Filer)
- SECTricida Inc. filed SEC Form 8-K: Bankruptcy or Receivership, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Tricida, Inc. (0001595585) (Filer)
- SECTricida Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Tricida, Inc. (0001595585) (Filer)
- SECTricida Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Tricida, Inc. (0001595585) (Filer)
- SECTricida Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Tricida, Inc. (0001595585) (Filer)
- SECTricida Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits8-K - Tricida, Inc. (0001595585) (Filer)
- SECSEC Form 25-NSE filed by Tricida Inc.25-NSE - Tricida, Inc. (0001595585) (Subject)
- SECTricida Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Tricida, Inc. (0001595585) (Filer)
- SECTricida Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Tricida, Inc. (0001595585) (Filer)
- 13D/GSEC Form SC 13G/A filed by Tricida Inc. (Amendment)SC 13G/A - Tricida, Inc. (0001595585) (Subject)
- 13D/GSEC Form SC 13G/A filed by Tricida Inc. (Amendment)SC 13G/A - Tricida, Inc. (0001595585) (Subject)
- 13D/GSEC Form SC 13G/A filed by Tricida Inc. (Amendment)SC 13G/A - Tricida, Inc. (0001595585) (Subject)
- 13D/GSEC Form SC 13G/A filed by Tricida Inc. (Amendment)SC 13G/A - Tricida, Inc. (0001595585) (Subject)
- SECTricida Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Tricida, Inc. (0001595585) (Filer)
- NEWS12 Health Care Stocks Moving In Monday's Intraday SessionGainers Jaguar Health (NASDAQ:JAGX) stock rose 6215.8% to $5.35 during Monday's regular session. The current volume of 532.2K shares is 6.8% of Jaguar Health's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $808.9 million. Intelligent Bio Solutions (NASDAQ:INBS) stock increased by 424.84% to $1.38. As of 12:30 EST, Intelligent Bio Solutions's stock is trading at a volume of 115.7 million, which is 206846.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $25.2 million. Pliant Therapeutics (NASDAQ:PLRX) stock rose 46.3% to $32.93. Trading volume for this
- NEWSStocks That Hit 52-Week Lows On MondayOn Monday, 12 stocks hit new 52-week lows. Noteable 52-Week Lows: Innovative Ind Props (NYSE:IIPR) was the largest, in terms of market cap, to set a new 52-week low. Tricida (NASDAQ:TCDA) was the smallest company by market cap to set a new 52-week low. Amesite (NASDAQ:AMST) saw the most pronounced move, as shares traded down 17.22% to hit its new 52-week low. Clough Global Equity (AMEX:GLQ) shares actually gained 0.16%, rebounding after it reached its 52-week low. Stocks dropping to new 52-week lows on Monday: Innovative Ind Props (NYSE:IIPR) stock broke to a new 52-week low of $87.20 on Monday. Shares of the company traded up 0.92%. Pacira BioSciences (NASDAQ:PCRX) shares ma
- NEWSStocks That Hit 52-Week Lows On FridayFriday saw 23 companies set new 52-week lows. Significant Points From Today's 52-Week Lows: L3Harris Technologies (NYSE:LHX) was the largest firm by market cap to set a new 52-week low. The smallest company on a market cap basis to set a new 52-week low was Digital Brands Group (NASDAQ:DBGI). Windtree Therapeutics (NASDAQ:WINT) saw the most pronounced move, as shares traded down 26.62% to hit its new 52-week low. Arqit Quantum (NASDAQ:ARQQ) saw the biggest bounce back on, as shares traded up 0.0% to rebound after it hit its new 52-week low. Stocks that set new 52-week lows on Friday are as follows: L3Harris Technologies (NYSE:LHX) stock set a new 52-week low of $190.11 on Frid
- NEWS12 Health Care Stocks Moving In Thursday's Pre-Market SessionGainers Apexigen (NASDAQ:APGN) shares moved upwards by 39.7% to $2.5 during Thursday's pre-market session. The company's market cap stands at $56.4 million. Hyperfine (NASDAQ:HYPR) shares increased by 14.75% to $1.01. The company's market cap stands at $71.2 million. Tricida (NASDAQ:TCDA) stock rose 13.2% to $0.16. The company's market cap stands at $9.0 million. Sonnet BioTherapeutics (NASDAQ:SONN) shares increased by 11.91% to $1.41. The company's market cap stands at $11.1 million. Zymeworks BC (NASDAQ:ZYME) stock moved upwards by 11.5% to $11.15. The market value of their outstanding shares is at $702.4 million. RenovoRx (NASDAQ:RNXT) stock rose 9.58% to $4.0. The company's market
- NEWSWhy Starbox Group Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving PremarketGainers Tricida, Inc. (NASDAQ:TCDA) rose 37.7% to $0.1898 in pre-market trading after gaining 4% on Wednesday. Huadi International Group Co., Ltd. (NASDAQ:HUDI) rose 26.7% to $7.16 in pre-market trading after gaining over 3% on Wednesday. Starbox Group Holdings Ltd. (NASDAQ:STBX) shares rose 22.1% to $3.65 in pre-market trading after the company reported a rise in FY22 earnings. AIM ImmunoTech Inc. (NYSE:AIM) shares rose 15.8% to $0.73 in pre-market trading after dropping 18% on Wednesday. AIM ImmunoTech recently entered into a sponsored collaborative clinical research agreement with Erasmus MC and AstraZeneca. Zymeworks Inc. (NASDAQ:ZYME) rose 12% to $11.20 in pre-market trading. B
- NEWSWhy Ontrak Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionGainers Ontrak, Inc. (NASDAQ:OTRK) shares jumped 101.7% to $1.1599 after the company announced new data that shows a reduction in depression and axiety symptoms for Ontrak Health's Wholehealth+ program members. Aceragen Inc. (NASDAQ:ACGN) shares gained 61.3% to $11.65. TC Biopharm (Holdings) Plc (NASDAQ:TCBP) gained 44% to $7.07 after the company on Tuesday announced a strategic collaboration to advance gamma-delta T cells in oncology. Energy Vault Holdings, Inc. (NYSE:NRGV) shares gained 42.4% to $5.08 after the company updated Q4 and FY22 expected revenue results. G Medical Innovations Holdings Ltd (NASDAQ:GMVD) jumped 34.6% to $4.66. Sigilon Therapeutics, Inc. (NASDAQ:SGTX) cli
TCDA FAQ
8 questionsWhat does Tricida Inc. do?
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of TRC101, a non-absorbed orally-administered polymer that has completed phase 3 trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company was incorporated in 2013 and is headquartered in South San Francisco, California.What is the latest news on TCDA?
Quantisnow has not tracked any new filings, ratings or press releases for TCDA in the last 30 days. The most recent wire item was published on June 20, 2023.Where does TCDA stock trade?
Tricida Inc. (TCDA) is listed on NASDAQ.What sector and industry is TCDA in?
Tricida Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did Tricida Inc. go public?
Tricida Inc. (TCDA) completed its IPO in 2018.What are analysts saying about TCDA?
Across the last 2 analyst actions on Tricida Inc., there was 1 upgrade and 0 downgrades. The most recent action was from Goldman: Buy with a $25.00 price target on 2022-04-13. Recent price targets range from $7.00 to $25.00.What companies are similar to TCDA?
Notable peers in the same industry include AZN (AstraZeneca PLC), JNJ (Johnson & Johnson), ABT (Abbott Laboratories), MRK (Merck & Company Inc.), ABBV (AbbVie Inc.). Compare TCDA side-by-side with any of them on Quantisnow.How can I track TCDA on Quantisnow?
Quantisnow aggregates Tricida Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow TCDA to receive live email and push alerts on every new disclosure.